http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015199534-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e6e4a54a61ccf2f9cb4d46d5160eafe6 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2014-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51a6b04e3ff1eb9d6b6ea67ea9815e12 |
| publicationDate | 2015-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2015199534-A1 |
| titleOfInvention | Determining encapsulating peritoneal sclerosis |
| abstract | Patients on peritoneal dialysis are at risk for developing encapsulating peritoneal sclerosis (EPS) The present invention is directed to a method to diagnose or determine the risk for encapsulating peritoneal sclerosis (EPS) in a patient. An increase in soluble CD25 indicates EPS or a risk for developing EPS in said patient. The invention is also directed to a kit for carrying out measurement of soluble CD25. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11255844-B2 |
| priorityDate | 2014-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.